Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Growth (Status and Outlook) 2023-2029
The global Pharmaceutical Contract Sales Outsourcing (CSO) market size is projected to grow from US$ xx million in 2023 to US$ xx million in 2029; it is expected to grow at a CAGR of xx% from 2023 to 2029.
LPI (LP Information)' newest research report, the “Pharmaceutical Contract Sales Outsourcing (CSO) Industry Forecast” looks at past sales and reviews total world Pharmaceutical Contract Sales Outsourcing (CSO) sales in 2022, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Contract Sales Outsourcing (CSO) sales for 2023 through 2029. With Pharmaceutical Contract Sales Outsourcing (CSO) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Contract Sales Outsourcing (CSO) industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Contract Sales Outsourcing (CSO) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Contract Sales Outsourcing (CSO) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Contract Sales Outsourcing (CSO) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Contract Sales Outsourcing (CSO) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Contract Sales Outsourcing (CSO).
United States market for Pharmaceutical Contract Sales Outsourcing (CSO) is estimated to increase from US$ xx million in 2022 to US$ xx million by 2029, at a CAGR of xx% from 2023 through 2029.
China market for Pharmaceutical Contract Sales Outsourcing (CSO) is estimated to increase from US$ xx million in 2022 to US$ xx million by 2029, at a CAGR of xx% from 2023 through 2029.
Europe market for Pharmaceutical Contract Sales Outsourcing (CSO) is estimated to increase from US$ xx million in 2022 to US$ xx million by 2029, at a CAGR of xx% from 2023 through 2029.
Global key Pharmaceutical Contract Sales Outsourcing (CSO) players cover China Medical System (CMS), IQVIA, PHOENIX Group, and EVERSANA, etc. In terms of revenue, the global two largest companies occupied for a share nearly XX% in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Contract Sales Outsourcing (CSO) market by product type, application, key players and key regions and countries.
Segmentation by type
Cardiovascular Disorders
Oncology
Metabolic Disorders
Neurology
Others
Segmentation by application
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
China Medical System (CMS)
IQVIA
PHOENIX Group
EVERSANA
Ashfield Engage (Inizio)
Amplity Health
Sinco Pharma
Syneos Health
EPS Corporation
Uniphar Group
CMIC Group
SciClone Pharmaceuticals
China Pioneer Pharma
Promoveo Health
CSO Pharmitalia
GTS Solution
QFR Solutions
Please note: The report will take approximately 2 business days to prepare and deliver.
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size 2018-2029
- 2.1.2 Pharmaceutical Contract Sales Outsourcing (CSO) Market Size CAGR by Region 2018 VS 2022 VS 2029
- 2.2 Pharmaceutical Contract Sales Outsourcing (CSO) Segment by Type
- 2.2.1 Cardiovascular Disorders
- 2.2.2 Oncology
- 2.2.3 Metabolic Disorders
- 2.2.4 Neurology
- 2.2.5 Others
- 2.3 Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Type
- 2.3.1 Pharmaceutical Contract Sales Outsourcing (CSO) Market Size CAGR by Type (2018 VS 2022 VS 2029)
- 2.3.2 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Market Share by Type (2018-2023)
- 2.4 Pharmaceutical Contract Sales Outsourcing (CSO) Segment by Application
- 2.4.1 Hospital
- 2.4.2 Clinic
- 2.4.3 Others
- 2.5 Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application
- 2.5.1 Pharmaceutical Contract Sales Outsourcing (CSO) Market Size CAGR by Application (2018 VS 2022 VS 2029)
- 2.5.2 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Market Share by Application (2018-2023)
- 3 Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Player
- 3.1 Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Market Share by Players
- 3.1.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Players (2018-2023)
- 3.1.2 Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share by Players (2018-2023)
- 3.2 Global Pharmaceutical Contract Sales Outsourcing (CSO) Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
- 4 Pharmaceutical Contract Sales Outsourcing (CSO) by Regions
- 4.1 Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Regions (2018-2023)
- 4.2 Americas Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Growth (2018-2023)
- 4.3 APAC Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Growth (2018-2023)
- 4.4 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Growth (2018-2023)
- 4.5 Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Growth (2018-2023)
- 5 Americas
- 5.1 Americas Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country (2018-2023)
- 5.2 Americas Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Type (2018-2023)
- 5.3 Americas Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application (2018-2023)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Region (2018-2023)
- 6.2 APAC Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Type (2018-2023)
- 6.3 APAC Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application (2018-2023)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 7 Europe
- 7.1 Europe Pharmaceutical Contract Sales Outsourcing (CSO) by Country (2018-2023)
- 7.2 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Type (2018-2023)
- 7.3 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application (2018-2023)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) by Region (2018-2023)
- 8.2 Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Type (2018-2023)
- 8.3 Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application (2018-2023)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
- 10.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Forecast by Regions (2024-2029)
- 10.1.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Forecast by Regions (2024-2029)
- 10.1.2 Americas Pharmaceutical Contract Sales Outsourcing (CSO) Forecast
- 10.1.3 APAC Pharmaceutical Contract Sales Outsourcing (CSO) Forecast
- 10.1.4 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Forecast
- 10.1.5 Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Forecast
- 10.2 Americas Pharmaceutical Contract Sales Outsourcing (CSO) Forecast by Country (2024-2029)
- 10.2.1 United States Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
- 10.2.2 Canada Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
- 10.2.3 Mexico Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
- 10.2.4 Brazil Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
- 10.3 APAC Pharmaceutical Contract Sales Outsourcing (CSO) Forecast by Region (2024-2029)
- 10.3.1 China Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
- 10.3.2 Japan Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
- 10.3.3 Korea Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
- 10.3.4 Southeast Asia Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
- 10.3.5 India Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
- 10.3.6 Australia Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
- 10.4 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Forecast by Country (2024-2029)
- 10.4.1 Germany Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
- 10.4.2 France Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
- 10.4.3 UK Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
- 10.4.4 Italy Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
- 10.4.5 Russia Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
- 10.5 Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Forecast by Region (2024-2029)
- 10.5.1 Egypt Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
- 10.5.2 South Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
- 10.5.3 Israel Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
- 10.5.4 Turkey Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
- 10.5.5 GCC Countries Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
- 10.6 Global Pharmaceutical Contract Sales Outsourcing (CSO) Forecast by Type (2024-2029)
- 10.7 Global Pharmaceutical Contract Sales Outsourcing (CSO) Forecast by Application (2024-2029)
- 11 Key Players Analysis
- 11.1 China Medical System (CMS)
- 11.1.1 China Medical System (CMS) Company Information
- 11.1.2 China Medical System (CMS) Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
- 11.1.3 China Medical System (CMS) Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
- 11.1.4 China Medical System (CMS) Main Business Overview
- 11.1.5 China Medical System (CMS) Latest Developments
- 11.2 IQVIA
- 11.2.1 IQVIA Company Information
- 11.2.2 IQVIA Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
- 11.2.3 IQVIA Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
- 11.2.4 IQVIA Main Business Overview
- 11.2.5 IQVIA Latest Developments
- 11.3 PHOENIX Group
- 11.3.1 PHOENIX Group Company Information
- 11.3.2 PHOENIX Group Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
- 11.3.3 PHOENIX Group Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
- 11.3.4 PHOENIX Group Main Business Overview
- 11.3.5 PHOENIX Group Latest Developments
- 11.4 EVERSANA
- 11.4.1 EVERSANA Company Information
- 11.4.2 EVERSANA Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
- 11.4.3 EVERSANA Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
- 11.4.4 EVERSANA Main Business Overview
- 11.4.5 EVERSANA Latest Developments
- 11.5 Ashfield Engage (Inizio)
- 11.5.1 Ashfield Engage (Inizio) Company Information
- 11.5.2 Ashfield Engage (Inizio) Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
- 11.5.3 Ashfield Engage (Inizio) Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
- 11.5.4 Ashfield Engage (Inizio) Main Business Overview
- 11.5.5 Ashfield Engage (Inizio) Latest Developments
- 11.6 Amplity Health
- 11.6.1 Amplity Health Company Information
- 11.6.2 Amplity Health Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
- 11.6.3 Amplity Health Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
- 11.6.4 Amplity Health Main Business Overview
- 11.6.5 Amplity Health Latest Developments
- 11.7 Sinco Pharma
- 11.7.1 Sinco Pharma Company Information
- 11.7.2 Sinco Pharma Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
- 11.7.3 Sinco Pharma Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
- 11.7.4 Sinco Pharma Main Business Overview
- 11.7.5 Sinco Pharma Latest Developments
- 11.8 Syneos Health
- 11.8.1 Syneos Health Company Information
- 11.8.2 Syneos Health Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
- 11.8.3 Syneos Health Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
- 11.8.4 Syneos Health Main Business Overview
- 11.8.5 Syneos Health Latest Developments
- 11.9 EPS Corporation
- 11.9.1 EPS Corporation Company Information
- 11.9.2 EPS Corporation Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
- 11.9.3 EPS Corporation Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
- 11.9.4 EPS Corporation Main Business Overview
- 11.9.5 EPS Corporation Latest Developments
- 11.10 Uniphar Group
- 11.10.1 Uniphar Group Company Information
- 11.10.2 Uniphar Group Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
- 11.10.3 Uniphar Group Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
- 11.10.4 Uniphar Group Main Business Overview
- 11.10.5 Uniphar Group Latest Developments
- 11.11 CMIC Group
- 11.11.1 CMIC Group Company Information
- 11.11.2 CMIC Group Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
- 11.11.3 CMIC Group Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
- 11.11.4 CMIC Group Main Business Overview
- 11.11.5 CMIC Group Latest Developments
- 11.12 SciClone Pharmaceuticals
- 11.12.1 SciClone Pharmaceuticals Company Information
- 11.12.2 SciClone Pharmaceuticals Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
- 11.12.3 SciClone Pharmaceuticals Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
- 11.12.4 SciClone Pharmaceuticals Main Business Overview
- 11.12.5 SciClone Pharmaceuticals Latest Developments
- 11.13 China Pioneer Pharma
- 11.13.1 China Pioneer Pharma Company Information
- 11.13.2 China Pioneer Pharma Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
- 11.13.3 China Pioneer Pharma Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
- 11.13.4 China Pioneer Pharma Main Business Overview
- 11.13.5 China Pioneer Pharma Latest Developments
- 11.14 Promoveo Health
- 11.14.1 Promoveo Health Company Information
- 11.14.2 Promoveo Health Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
- 11.14.3 Promoveo Health Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
- 11.14.4 Promoveo Health Main Business Overview
- 11.14.5 Promoveo Health Latest Developments
- 11.15 CSO Pharmitalia
- 11.15.1 CSO Pharmitalia Company Information
- 11.15.2 CSO Pharmitalia Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
- 11.15.3 CSO Pharmitalia Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
- 11.15.4 CSO Pharmitalia Main Business Overview
- 11.15.5 CSO Pharmitalia Latest Developments
- 11.16 GTS Solution
- 11.16.1 GTS Solution Company Information
- 11.16.2 GTS Solution Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
- 11.16.3 GTS Solution Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
- 11.16.4 GTS Solution Main Business Overview
- 11.16.5 GTS Solution Latest Developments
- 11.17 QFR Solutions
- 11.17.1 QFR Solutions Company Information
- 11.17.2 QFR Solutions Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
- 11.17.3 QFR Solutions Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
- 11.17.4 QFR Solutions Main Business Overview
- 11.17.5 QFR Solutions Latest Developments
- 12 Research Findings and Conclusion
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook